Doctors treat blood clots using several approaches depending on where the clot is, how large it is, and how much danger it poses. The options range from blood-thinning medications that stop a clot from growing while your body breaks it down naturally, to emergency procedures that physically extract or dissolve a clot within hours. Most people with a deep vein thrombosis (DVT) or pulmonary embolism (PE) are treated with anticoagulant medications for three to six months. Life-threatening clots in the brain, lungs, or heart may require clot-dissolving drugs or surgical removal.
Blood Thinners: The Most Common Treatment
Anticoagulants, commonly called blood thinners, are the standard first-line treatment for most blood clots. They don’t actually dissolve the clot. Instead, they prevent the clot from growing larger and stop new clots from forming, which gives your body’s own clot-clearing system time to do its work. Your body has enzymes that gradually break down clot material on their own, and blood thinners create the conditions for that process to succeed.
There are several types. Older medications like warfarin work by depleting vitamin K, which your body needs to produce certain clotting factors. Without enough vitamin K, those factors can’t activate, and the clotting process slows dramatically. Warfarin requires regular blood tests to make sure the dose is keeping your blood in the right range. Newer oral medications, often called DOACs, work differently. They block specific proteins in the clotting chain directly, occupying the active site of those proteins so they can’t do their job. These newer drugs don’t require routine blood monitoring, which makes them more convenient for most patients.
Heparin, given by injection or IV, works faster than pills and is often used in hospitals to get immediate protection while oral medications take effect. The typical course of anticoagulant treatment lasts three to six months, though some people stay on blood thinners longer if they have an ongoing risk factor like a clotting disorder or cancer.
Clot-Dissolving Medications
When a clot is immediately life-threatening, doctors may use thrombolytics, often called “clot busters.” These are powerful drugs that actively break apart an existing clot rather than waiting for the body to do it. The most widely used is alteplase (tPA), and the situations where it’s given are tightly defined because the drug carries a real risk of serious bleeding, including bleeding in the brain.
For an ischemic stroke (a clot blocking blood flow to the brain), tPA must be given within 4.5 hours from when symptoms started. The entire dose is delivered intravenously over about an hour. Every minute matters here because brain tissue is dying while blood flow is blocked.
For a pulmonary embolism, thrombolytics are reserved for the most dangerous cases, specifically when the clot causes a significant drop in blood pressure (below 90 mmHg). In these situations, the drug is infused over two hours. Doctors don’t use clot busters for smaller or more stable PEs because the bleeding risk outweighs the benefit when the patient isn’t in immediate hemodynamic danger.
Catheter-Directed Thrombolysis
Rather than flooding the entire bloodstream with a clot-dissolving drug, doctors can thread a thin catheter through a blood vessel directly to the clot and deliver the medication right where it’s needed. This is called catheter-directed thrombolysis (CDT), and it uses a much smaller dose of medication concentrated at the clot site.
The results are striking. A large review of over 20,000 patients found that CDT cut the risk of death by more than half compared to standard anticoagulation alone for intermediate- and high-risk pulmonary embolisms. Compared to system-wide thrombolytic therapy, CDT was associated with 57% lower odds of death and 56% lower odds of bleeding in the brain. The rate of major bleeding was also about 39% lower than with full-body thrombolysis. These advantages have led some experts to suggest CDT should be considered a first-line option for serious PE cases.
Mechanical Thrombectomy
In a mechanical thrombectomy, doctors physically remove the clot using specialized tools threaded through a catheter, typically inserted through a puncture in the groin. There are two main techniques.
The first uses a stent retriever. A balloon-guided catheter is advanced to the clot, and a small wire is threaded through it. An expandable stent is then deployed inside the clot. The stent opens up, and its projections grip the clot material, essentially trapping it. The stent is then slowly pulled back through the catheter, dragging the clot out with it. The balloon is briefly inflated during retrieval to stop blood flow temporarily and prevent clot fragments from escaping downstream.
The second technique, called direct aspiration, is more straightforward. A large-bore catheter is advanced until it contacts the clot, and then powerful suction is applied using an aspiration pump or large syringe. The negative pressure pulls the clot into the catheter and out of the body. For larger clots in bigger vessels, specialized systems can core the clot away from the vessel wall and collect it in a bag built into the catheter to prevent fragments from breaking loose.
A recent randomized trial (STORM-PE) found that mechanical thrombectomy achieved 100% technical success in removing clots from patients with serious pulmonary embolisms. Patients who underwent thrombectomy showed significantly greater reduction in heart strain at 48 hours compared to those treated with blood thinners alone. Nearly 40% of thrombectomy patients had their heart function return to normal within 48 hours, compared to about 14% in the medication-only group. The rate of major complications was similar between the two groups.
When Emergency Surgery Is Needed
Surgical embolectomy, where a surgeon opens the chest and physically removes a clot from the pulmonary arteries, is reserved for the most critical situations. The American Heart Association defines these high-risk patients by specific markers: blood pressure below 90 mmHg lasting at least 15 minutes, a drop of more than 40 mmHg from their baseline, the need for drugs to support blood pressure, cardiac arrest, or a dangerously slow heart rate below 40 beats per minute caused by the clot. These patients also show signs of strain on the right side of the heart, visible on imaging as an enlarged right ventricle.
This is a last-resort procedure, typically used when thrombolytics have failed, when the patient can’t receive clot-dissolving drugs due to a high bleeding risk (such as recent surgery or a brain hemorrhage), or when the patient is deteriorating too quickly for less invasive options to work.
IVC Filters: Blocking Clots From Reaching the Lungs
An inferior vena cava (IVC) filter is a small metal device placed inside the body’s largest vein, which carries blood from the lower body back to the heart. The filter catches clots traveling upward before they can reach the lungs and cause a pulmonary embolism. It doesn’t treat or dissolve existing clots. It’s a barrier.
IVC filters are recommended for a narrow set of circumstances: patients who have a blood clot but absolutely cannot take blood thinners (because of active bleeding or a very high bleeding risk), patients who developed serious complications from anticoagulants, or patients whose clots keep growing despite adequate anticoagulation. Modern retrievable filters can be removed once the immediate danger has passed and the patient can safely start blood thinners.
How Long Clots Take to Resolve
Once a clot is stabilized with blood thinners, your body’s natural enzymes gradually dissolve it over weeks to months. There’s no fixed timeline because it depends on the clot’s size, location, and your individual biology. Most treatment courses run three to six months, and during that time, the clot is slowly being reabsorbed. Some large clots never fully dissolve and instead become scar tissue attached to the vessel wall.
After a DVT, doctors often recommend wearing below-knee compression stockings with at least 23 mmHg of pressure at the ankle. UK guidelines suggest wearing them for at least two years starting about a week after diagnosis or once swelling has gone down. The goal is to reduce the risk of post-thrombotic syndrome, a chronic condition where the affected leg stays swollen, achy, or discolored because the clot damaged the vein’s valves. Not everyone develops this, but consistent compression significantly lowers the chances.